Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.
about
Interventions for improving adherence to ocular hypotensive therapyInterventions to improve adherence to lipid lowering medicationInterventions for improving adherence to ocular hypotensive therapyInterventions to improve adherence to lipid lowering medicationThe impact of non-compliance on the cost-effectiveness of pharmaceuticals: a review of the literature.Attributes Associated with Adherence to Glaucoma Medical Therapy and its Effects on Glaucoma Outcomes: An Evidence-Based Review and Potential Strategies to Improve Adherence.The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review.Development and preliminary results of the Financial Incentive Coercion Assessment questionnaire.Economic impact of poor compliance with pharmaceuticals.Cost offset of lipid-lowering drugs for primary and secondary prevention of cardiovascular disease.Risk for cost-related medication nonadherence among emergency department patients.Pharmaceutical use and outcomes: always a need for a sober second look.Resident physician and hospital pharmacist familiarity with patient discharge medication costs.Baseline information in structural failure time estimators for the effect of observed treatment compliance.
P2860
Q24197680-1A56F964-5923-486C-A8C9-62BD977F18A9Q24236817-65629881-89D6-47BF-BF19-66A196E2D49FQ24241641-E229F67E-635C-442A-81DE-CB60893272C9Q24245739-20FF04FC-C932-43C5-AF34-6609B3A57449Q34464972-9D16B801-0263-48EF-A078-433AC9871C31Q36177075-BA595972-69F6-4C9D-B0B0-6F8241D17DCCQ36573967-8B3C0AB5-ACD5-4195-B18C-F32060A75DDCQ36982091-F41979CE-9DC0-4716-B801-669CACAD0559Q37609268-80CBA9F4-D477-43F1-844B-DE5A20CDA21BQ37609394-6BF427DE-5415-4458-AF8F-EC724FC22C0FQ39974872-95F4D3CC-6C4A-421E-8B7F-FDB9E4BB61E7Q42115963-A3CBACE7-AA71-4DEF-87D3-A3175210B7C9Q43527824-E0F01D0C-2338-4170-B692-A0EDA84893D4Q49044408-E35B0381-5886-43DC-8350-B1FC9F881A66
P2860
Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens.
description
1999 nî lūn-bûn
@nan
1999 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մարտին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@ast
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@en
type
label
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@ast
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@en
prefLabel
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@ast
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@en
P1433
P1476
Pharmacoeconomic consequences ...... with prescribed drug regimens.
@en
P2093
Urquhart J
P304
P356
10.2165/00019053-199915030-00002
P577
1999-03-01T00:00:00Z
P6179
1032726922